Delivery Order SPE2DB20D2001-SPE2DB26FPLJH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a $16,631.46 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on September 25, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $9,023.70 on August 8, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The delivery order is scheduled for completion by August 11, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $27,727.45. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $55,353.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The work will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $58,152.56. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by October 21, 2025, with performance fulfilled from the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,514.30 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price contract is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of October 21,...
- The Defense Logistics Agency awarded a $21,654.75 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed price delivery order is set to be completed by August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB26FPLJHDelivery Order
The Defense Logistics Agency (DLA) awarded a $17,587.91 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within AmerisourceBergen's broader federal contract portfolio and reflects the company's role as a critical pharmaceutical supplier to the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Eliquis, an anticoagulant medication, aligns with the therapeutic range of products the contractor regularly supplies under this strategic vehicle for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 10/23/25 |